Volume : 10, Issue : 04, April – 2023
Title:
23.CHEMOPREVENTION OF CANCER
Authors :
Sampada.U.Shelke, Tanushri.P.Bawane, Vedashri Umap, Abhishek Barathe, Dr.Nishan Bobade, Varsha Rathod
Abstract :
Cancer chemo prevention refers to the use of agents for the inhibition, delay, or reversal of carcinogens before invasion. In the present review, agents examined in the context of cancer chemo prevention are classified in four major categories—hormonal, medications, diet-related agents, and vaccines—and the main representatives of each category are presented. Although there are serious constraints in the documentation of effectiveness of chemo preventive agents, mainly stemming from the long latency of the condition they are Addressing and the frequent lack of intermediate biomarkers, there is little disagreement about the role of aspirin, whereas a diet rich in vegetables and fruits appears to convey more protection than individual micro nutrients. Among categories of cancer chemo preventive agents, hormonal ones and vaccines might hold more promise for the future. Also, the identification of individuals who would benefit most from chemo preventive interventions on the basis of their genetic profiles could open new prospects for cancer chemo prevention.
Cite This Article:
Please cite this article in press Sampada.U.Shelke et al, Chemoprevention Of Cancer ., Indo Am. J. P. Sci, 2023; 10 (04).
Number of Downloads : 10
References:
1. World Cancer Report 2014. Stewart BW and Wild CP, Eds. IARC (WHO). Lyon, France: 2014.Reference Source Ferlay J, Soerjomataram I, Ervik M, et al.: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
2. Biomarkers in Cancer Chemoprevention. IARC Scientific Publications No. 154. Eds Miller AB, Bartsch H, Boffeta P, Dragsted L, and Vainio H. International Agency for Cancer Research. Lyon, 2001.
3. A Report on Chemoprevention of Cancer Reference Source Sporn MB, Dunlop NM, Newton DL, et al.: Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc. 1976; 35(6):
1332–8. PubMed Abstract.
4. Tamimi RM, Lagiou P, Adami HO, et al.: Prospects for chemoprevention of cancer. J Intern Med. 2002; 251(4): 286–300. PubMed Abstract| Publisher Full Text
5. Mirkin S, Pickar JH: Selective estrogen receptor modulators (SERMs): a review of clinical data. Maturitas. 2015; 80(1): 52–7. PubMed Abstract | Publisher Full Text
6. KurahashiN, Iwasaki M, Sasazuki S,Otani T, Inoue M, Tsugane S. Soy product and isoflavone consumption in relation to prostate cancerin Japanese men. Cancer Epidemiol Biomarkers Prev 2007; 16: 538-45.
7. Rose DP. Dietary fatty acids and cancer. Am J Clin Nutr 1997; 66 (4 Suppl): 998S1003S.Dorai T, Aggarwal BB. Role of chemo preventive agents in cancer therapy. Cancer Lett 2004; 215: 129-40.
8. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 76880.Vaisman N, Arber N. The role of nutrition and chemoprevention in colorectal cancer: observation to expectations. Best Pract Res Clin Gastroenterol 2002; 16: 201-17
9. Ales-Martinez, J. E., Ruiz, A., Chacon, J. I., Lluch Hernandez, A., Ramos, M., Cordoba, O., et al. (2015). Preventive treatments for breast cancer: recent developments. Clin. Transl. Oncol. 17, 257–263. doi: 10.1007/s12094-014-1250-2 12.Alizadeh, A. M.,
10. Khaniki, M., Azizian, S., Mohaghgheghi, M. A., Sadeghizadeh, M., and Najafi, F.(2012). Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier–curcumin. Eur..J. Pharmacol. 689, 226–232. doi:10.1016/j.ejphar.2012.06.016
11. American Cancer Society (2019a). Cancer statistics center, American Cancer Society. [Online]. Available: https://cancerstatisticscenter.cancer.org/#!/ [Accessed 2019/12/12].
12. American Cancer Society (2019b). Key Statistics for Lung Cancer, American Cancer Society. [Online]. Available: https://www.cancer.org/cancer/lungcancer/about/keys tatistics.html [Accessed 2019/12/12].
13. Arulmozhi, V., Pandian, K., and Mirunalini, S. (2013). Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf. B B. 14. 110, 313–320. doi: 10.1016/j.colsurfb .2013.03.039
14. Gibaud S, Andreux JP, Weingarten C, Renard M, Cou-vreur P. Eur. J. Cancer. 1994; 30A(6):820– 826. [PubMed: 7917543]
15. Adamson IY. Environ. Health Perspect. 1976; 16:119–125. [PubMed: 65280] Parvinen LM, Kilkku P, Makinen E, Liukko P, Gronroos M. Acta Radiol. Oncol. 1983; 22(6):417– 421. [PubMed: 6203333] Karam H, Hurbain-Kosmath I, Housset B. Toxicol. Lett. 1995; 76(2):155–163. [PubMed: 7536963]
16. Cohen IS, Mosher MB, O’KeefeEJ, KlausSN, De Conti RC. Arch. Dermatol. 1973; 18. 107(4):553– 555. [PubMed: 4121404] Fraiser LH, Kanekal S, Kehrer JP. Drugs. 1991; 42(5):781–795. [PubMed: 1723374]
17. A Report on Chemoprevention of Cancer Taneja, SC.; Qazi, GN. Bioactive Molecues in Medicinal Plants: A perspective in their therapeutic action, in Drug discovery and development. Chorghade, MS., editor. John Wiley and Sons, Inc; 2007. p. 1-50.
18. Pettit GR, Tan R, Ichihara Y, Williams MD, Doubek DL, Tackett LP, Schmidt JM, Cerny RL, Boyd MR, Hooper JN. J. Nat. Prod. 1995; 58(6):961–965. [PubMed: 7673945] 24. Reddy VV, Sirsi M. Cancer Res. 1969; 29(7):1447–1451. [PubMed: 5799161]
19. Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. Ind. J. Exp. Biol. 1968; 6(4):232– 247. Singh SS, Srivastava S, Gupta VS, Patro B, Ghosh AC. Ind. J. Pharmacol. 2003; 35:83– 91.
20. Diwanay S, Chitre D, Patwardhan B. J. Ethnopharmacol. 2004; 90(1):49–55. [PubMed: 14698508] Nadkarni, KM.; Nadkarni, AK. Indian Materia medica. 3rd edition ed. Vol. Vol. 1. Bombay: Popular Prakashan Pvt. Ltd; 1976. p. 1220-1221.
21. Zhao TF, Wang XK, Rimando AM, Che CT. Planta Med. 1991; 57(5):505. [PubMed: 1798808] Mathew S, Kuttan G. J. Exp. Clin. Cancer Res. 1997; 16(4):407–411. [PubMed: 9505214]
22. Kobayashi NCC, Noronha SMRD. Cancer stem cells: a new approach to tumor development. Rev Assoc Med Bras 2015;61:86e93.
23. Yilmazer A. Cancer cell lines involving cancer stem cell populations respond to oxidative stress. Appl Biotechnol 2018;17:24e30.
24. Schrader TJ. Mutagens. In: Caballero B, Finglas PM, Toldra F, editors. Encyclopedia of food and health. Oxford: Academic Press; 2016. p. 20e8.
25. Kurzawa-Zegota M, Najafzadeh M, Baumgartner A, Anderson D. The protective effect of the flavonoids on foodmutagen-induced DNA damage in peripheral blood lymphocytes from colon cancer patients. Food Chem Toxicol 2012;50:124e9.
26. Basu AK, Nohmi T. Chemically-induced DNA damage, mutagenesis, and cancer. Int J Mol Sci 2018;19:1767.
27. Jrah-Harzallah H, Ben-Hadj-Khalifa S, Maloul A, El-Ghali R, MahjoubT.Thymoquinone effects on DMH-induced erythrocyte oxidative stress and haematological alterations during colon cancer promotion in rats. J Funct Foods 2013;5:1310e6.
28. Li W, He N, Tian L, Shi X, Yang X. Inhibitory effects of polyphenol-enriched extract from Ziyang tea against human breast cancer MCF-7 cells through reactive oxygen speciesdependent mitochondria molecular mechanism. J Food Drug Anal 2016;24:527e38.
29. Rodrı´guez-Enrı´quez S, Pacheco-Velazquez SC, Marı ´nHernandez A, Gallardo-P erez JC, Robledo-Cadena DX, Hernandez-Res endiz I, et al. Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol Appl Pharmacol2019;370:65e77.
30. Afrin S, Giampieri F, Forbes-Hernandez TY, Gasparrini M, Amici A, Cianciosi D, et al.
31. Manuka honey synergistically enhances the chemopreventive effect of 5-fluorouracil on human colon cancer cells by inducing oxidative stress and apoptosis, altering metabolic phenotypes and suppressing metastasis ability. Free Radic Biol Med 2018;126:41e54.
32. Deng J, Zhao L, Zhang N-Y, Karrow NA, Krumm CS, Qi D-S, et al. Aflatoxin B1 metabolism: regulation by phase I and II metabolizing enzymes and chemoprotective agents. Mutat Res Rev Mutat Res 2018;778:79e89.
33. A Report on Chemoprevention of Cancer Zhang Y. Phase II enzymes. In: Schwab M, editor. Encyclopedia of cancer. Berlin, Heidelberg: Springer Berlin Heidelberg; 2011. p. 2853e5.
34. Wang H, Leung LK. The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz [a] anthracene-induced MCF-7 cells. Nutrition 2010;26:1181e7.
35. Thangaraj K, Natesan K, Palani M, Vaiyapuri M. Orientin, a flavanoid, mitigates 1, 2 dimethylhydrazine-induced colorectal lesions in Wistar rats fed a high-fat diet. Toxicol Rep 2018;5:977e87.
36. Venkatachalam K, Gunasekaran S, Namasivayam N. Biochemical and molecular mechanisms underlying the chemopreventive efficacy of rosmarinic acid in a rat colon cancer. Eur J Pharmacol 2016;791:37e50.